Barbier, Michaela; Tomonaga, Yuki; Menges, Dominik; Haile, Sarah; Yebyo, Henock G; Puhan, Milo; Schwenkglenks, Matthias (2020). Cost-effectiveness and budget impact of docetaxel, abiraterone, enzalutamide, apalutamide or radiotherapy plus androgen deprivation therapy versus androgen deprivation therapy alone in newly diagnosed metastatic hormone-sensitive prostate cancer. Schweiz: Swiss Medical Board.
Statistics
Downloads
Additional indexing
| Item Type: | Published Research Report |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > Epidemiology, Biostatistics and Prevention Institute (EBPI) |
| Dewey Decimal Classification: | 610 Medicine & health |
| Language: | English |
| Date: | 6 July 2020 |
| Deposited On: | 13 Jan 2021 13:42 |
| Last Modified: | 08 Jul 2022 12:57 |
| Publisher: | Swiss Medical Board |
| Number of Pages: | 12 |
| Additional Information: | Health economic analysis plan Swiss Medical Board Health Technology Assessment Herausgeber: Swiss Medical Board und ECPM European Center for Pharmaceutical Medicine |
| OA Status: | Green |
| Free access at: | Official URL. An embargo period may apply. |
| Official URL: | https://www.swissmedicalboard.ch/fileadmin/public/news/2020/HealthEconomicAnalysisPlan_smb_prostate_cancer_drugs_2020.pdf |
Barbier, Michaela